Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1JAK 3 ritlecitinib----[1] 46 💬
2Ritlecitinib[1] Ritlecitinib (Ritlecitinib tosylate)[1] Ritlecitinib tosylate (Ritlecitinib tosylate, Ritlecitinib tosilate) 💬 [1] JAK3 💬 [15] Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬[1] 97 💬
3Ritlecitinib 10 MG[1] Ritlecitinib (Ritlecitinib tosylate)[1] Ritlecitinib tosylate (Ritlecitinib tosylate, Ritlecitinib tosilate) 💬 [1] JAK3 💬 [15] Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬[1] 97 💬
4Ritlecitinib 5 MG[1] Ritlecitinib (Ritlecitinib tosylate)[1] Ritlecitinib tosylate (Ritlecitinib tosylate, Ritlecitinib tosilate) 💬 [1] JAK3 💬 [15] Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬[1] 97 💬
5Ritlecitinib 50 MG[1] Ritlecitinib (Ritlecitinib tosylate)[1] Ritlecitinib tosylate (Ritlecitinib tosylate, Ritlecitinib tosilate) 💬 [1] JAK3 💬 [15] Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬[2] 96, 97 💬
6Ritlecitinib 50MG[1] Ritlecitinib (Ritlecitinib tosylate)[1] Ritlecitinib tosylate (Ritlecitinib tosylate, Ritlecitinib tosilate) 💬 [1] JAK3 💬 [15] Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬[1] 96 💬
7Ritlecitinib/JAK 3[1] Ritlecitinib (Ritlecitinib tosylate)[1] Ritlecitinib tosylate (Ritlecitinib tosylate, Ritlecitinib tosilate) 💬 [1] JAK3 💬 [15] Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬[1] 46 💬